TD Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Hold |
|
|||||
|
2025
Q1 | $540K | Hold |
|
|||||
|
2024
Q4 | $643K | Hold |
|
|||||
|
2024
Q3 | $1.52M | Hold |
|
|||||
|
2024
Q2 | $1.46M | Buy |
|
|||||
|
2024
Q1 | $2.15M | Buy |
|
|||||
|
2023
Q4 | $1.78M | Hold |
|
|||||
|
2023
Q3 | $1.35M | Buy |
|
|||||
|
2023
Q2 | $1.37M | Buy |
|
|||||
|
2023
Q1 | $424K | Hold |
|
|||||
|
2022
Q4 | $624K | Hold |
|
|||||
|
2022
Q3 | $1.33M | Hold |
|
|||||
|
2022
Q2 | $1.17M | Hold |
|
|||||
|
2022
Q1 | $907K | Buy |
|
|||||
|
2021
Q4 | $1.31M | Buy |
|
|||||
|
2021
Q3 | $1.67M | Buy |
|
|||||
|
2021
Q2 | $1.25M | Buy |
|